GL1X · GenesisL1 explorer

MolNFT v1 · #63534 · protein

Complex of UNG2 and a fragment-based designed inhibitor

3FCL · Uracil-DNA glycosylase: “Complex of UNG2 and a fragment-based designed inhibitor”. X-ray diffraction, 2 ligands (3FL, SCN), 3 pockets (best druggability 0.72). MolNFT v1 #63534 on GenesisL1: 3D structure, binding sites and pockets…

PDB
3FCL
Type
protein
Length
444 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uracil-DNA glycosylase
EC
3.2.2.-
UniProt
P13051
Ligands
3FL, SCN
Pockets
3 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BUracil-DNA glycosylase (EC 3.2.2.-)protein22240% helix, 11% strandP13051

Ligands and binding sites

  • 3FL · 3-{[(4-{[(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]amino}butyl)amino]methyl}benzoic acid · ligand · 2 copies · chains A, B
  • SCN · Thiocyanate ion · ion · 8 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15790.720.80473FL, SCN
2600.590.9016SCN
31120.520.82293FL

Interfaces

1 interface between chains.

  • A–B · 543 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 3FCL · Complex of UNG2 and a fragment-based designed inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P13051 · AlphaFold monomer V2.0 prediction for uracil-DNA glycosylase (P13051) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.